IA2030 Scorecard

 — 

Global

  • Type to select a Country

SP 4: Life Course & Integration
4.1

Life-course vaccination

Breadth of protection (Mean Coverage across 12 antigens, %)—Global

Summary Table

Antigen2019202020212022
Mean71%69%68%72%
DTP386%83%81%84%
HPV14%12%13%15%
HEPB386%83%81%84%
HIB374%72%72%76%
IPV185%82%81%85%
MCV186%83%81%83%
MCV271%72%71%74%
PCV351%51%51%60%
POL387%83%81%84%
RCV169%68%66%68%
ROTAC40%47%48%51%
Definition: Mean coverage for all WHO-recommended vaccine antigens
  • Numerator: Sum of the coverage for the following antigens at the level of interest – Diphtheria, Tetanus, Pertussis, Hepatitis B, Haemophilus influenzae type B (Hib), Measles 1st dose (MCV), Measles 2nd dose (MCV2), pneumococcus, Oral Poliovirus Vaccine (OPV), Inactivated Poliovirus Vaccine (IPV), Rubella, Rotavirus, and Human Papillomavirus (HPV).
  • Denominator: Number of all antigens included for the indicator calculation, regardless of whether antigen has been introduced at the level of interest (denominator equals 13).
Method of estimation:

Step 1) Calculate the average of the coverage achieved at the level of interest (e.g., country level, global, WHO regional, etc.)

  • Following antigens are included, regardless of whether the antigen has been introduced – Diphtheria, Tetanus, Pertussis, Hepatitis B, Hib, Measles, Measles 2nd dose, Pneumo, Polio, IPV, Rubella, Rota, and HPV.
  • If coverage is not available at the level of interest, calculate coverage accordingly (weighted by population) before calculating the indicator value.
Data source: WHO/UNICEF Estimates of National Immunization Coverage (WUENIC), WHO/UNICEF HPV Estimates